daxor - DXR
DXR
Close Chg Chg %
9.78 -0.78 -7.98%
Closed Market
9.00
-0.78 (7.98%)
Volume: 36.61K
Last Updated:
Apr 6, 2026, 4:00 PM EDT
Company Overview: daxor - DXR
DXR Key Data
| Open $9.76 | Day Range 8.90 - 9.85 |
| 52 Week Range 7.10 - 15.00 | Market Cap $56.52M |
| Shares Outstanding 5.83M | Public Float 2.97M |
| Beta 0.15 | Rev. Per Employee N/A |
| P/E Ratio 5.27 | EPS -$1.69 |
| Yield 0.00% | Dividend $0.03 |
| EX-DIVIDEND DATE Jan 5, 2018 | SHORT INTEREST N/A |
| AVERAGE VOLUME 9.13K |
DXR Performance
| 1 Week | -7.01% | ||
| 1 Month | -20.70% | ||
| 3 Months | -36.43% | ||
| 1 Year | 18.06% | ||
| 5 Years | -21.90% |
DXR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 23.00 | |
| Number of Ratings | 2 | Current Quarters Estimate | -0.03 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | -0.21 | |
| Last Quarter’s Earnings | -0.11 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.05 | Next Fiscal Year Estimate | -0.03 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | 1 | 1 | 1 |
| Mean Estimate | -0.03 | -0.03 | -0.21 | -0.03 |
| High Estimates | -0.03 | -0.03 | -0.21 | -0.03 |
| Low Estimate | -0.03 | -0.03 | -0.21 | -0.03 |
| Coefficient of Variance | N/A | N/A | N/A | N/A |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Daxor - DXR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Daxor - DXR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Robert J. Michel Chief Financial Officer | 20,050 | Open market or private purchase of non-derivative security | 0.00 |
| Dec 12, 2025 | Jonathan Feldschuh Chief Scientific Officer; Director | 53,908 | Open market or private purchase of non-derivative security | 0.00 |
| Apr 8, 2025 | Michael R. Feldschuh Chief Executive Officer; Director | 212,694 | Open market or private purchase of non-derivative security Non-derivative transaction at $7.89 per share | 1,678,155.66 |